Raymond James Maintains Outperform on Axogen, Raises Price Target to $53

Raymond James analyst Jayson Bedford has maintained an 'Outperform' rating on Axogen (NASDAQ: AXGN) and raised the price target from $48 to $53. This adjustment reflects a positive outlook for the company in the market.